New Delhi, September 18, 2026 (Yes Punjab News)
The Food Safety and Standards Authority of India (FSSAI) on Friday said it has initiated three separate adjudication cases against Nestlé India over alleged regulatory non-compliance involving infant nutrition products, including NAN Excella Pro Stage 1 and Lactogen Pro 1.
According to a notice shared by the food regulator on Instagram, FSSAI examined the products and promotional material displayed on e-commerce platforms and flagged certain claims associated with the infant nutrition products.
In the case of NAN Excella Pro Stage 1, the regulator raised concerns over claims relating to “5 HMOS” and “Whey Protein”. For Lactogen Pro 1, FSSAI flagged a claim describing whey protein as easy to digest.
The regulator said it had sought clarifications from Nestlé India regarding the claims. Following its examination, FSSAI said the products were found to be in contravention of Regulation 4(2) of the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020.
The regulation places restrictions on promotional claims and material intended to enhance the saleability of infant foods. FSSAI also referred to Section 3 of the Infant Milk Substitutes, Feeding Bottles and Infant Foods (Regulation of Production, Supply and Distribution) Act, 1992, which prohibits the advertisement and promotion of such products.
Separately, FSSAI said a sample of a follow-up formula manufactured by Nestlé India was found to be sub-standard for its biotin content during laboratory testing.
The sample was subsequently sent to a referral laboratory for re-analysis. The second analysis also found the product to be non-conforming with the prescribed biotin requirement under the Foods for Infant Nutrition Regulations, 2020, according to the regulator.
FSSAI said three separate adjudication cases had been filed against Nestlé India in connection with the alleged promotional violations and the laboratory finding related to biotin content.
The regulator’s notice did not indicate that any final penalty had been imposed on the company.
Responding to the development, a Nestlé India spokesperson said the company’s products were fully compliant with all applicable regulations.
“The said products (i.e., NAN EXCELLA PRO & LACTOGEN PRO) and their labels were approved by the expert committee of FSSAI. In response to the notice, we have again submitted our detailed response to the authorities regarding statements appearing on the label, which are factual in nature, and supported by scientific literature,” the spokesperson said.
The company also said it adhered to all applicable regulations, including norms and label declarations prescribed under law.
“We confirm to adherence of all regulations including all norms and label declarations as per applicable laws. We will continue to work closely and support FSSAI in its efforts towards consumer awareness,” the spokesperson added.
FOLLOW NOW
